Baxter International Inc. (FRA:BTL)
Germany
· Delayed Price · Currency is EUR 15.69
-0.14 (-0.88%)
Last updated: Dec 4, 2025, 11:04 AM CET
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 6.08B | 5.85B |
Log In |
Log In |
Log In | Upgrade
|
| Emerging Markets Revenue | 1.35B | 1.35B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue | 3.60B | 3.44B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 11.02B | 10.64B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Americas Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| APAC Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Hillrom Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 11.02B | 10.64B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Medication Delivery Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Nutrition Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Infusion Therapies Revenue | 4.06B | 4.10B |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Surgery Revenue | 1.16B | 1.10B |
Log In |
Log In |
Log In | Upgrade
|
| Medical Products & Therapies Revenue | 5.23B | 5.21B |
Log In |
Log In |
Log In | Upgrade
|
| Patient Support Systems Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Solutions Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Care & Connectivity Solutions Revenue | 1.88B | 1.81B |
Log In |
Log In |
Log In | Upgrade
|
| Front Line Care Revenue | 1.15B | 1.14B |
Log In |
Log In |
Log In | Upgrade
|
| Healthcare Systems & Technologies Revenue | 3.03B | 2.95B |
Log In |
Log In |
Log In | Upgrade
|
| Injectables and Anesthesia Revenue | 1.38B | 1.37B |
Log In |
Log In |
Log In | Upgrade
|
| Drug Compounding Revenue | 1.09B | 1.04B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Revenue | 2.47B | 2.41B |
Log In |
Log In |
Log In | Upgrade
|
| Chronic Therapies Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Acute Therapies Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Kidney Care Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Revenue (Post-Q2 2023 Reporting) | 302.00M | 67.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -10.72B | -10.57B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 11.02B | 10.64B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| BioPharma Solutions Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Revenue (Pre-Q3 2023 Reporting) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 11.02B | 10.64B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Medical Products & Therapies Operating Income | 973.00M | 950.00M |
Log In |
Log In |
Log In | Upgrade
|
| Healthcare Systems & Technologies Operating Income | 460.00M | 468.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Operating Income | 285.00M | 313.00M |
Log In |
Log In |
Log In | Upgrade
|
| Kidney Care Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Operating Income | 23.00M | 18.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -1.76B | -1.74B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -14.00M | 14.00M |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Americas Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| APAC Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Hillrom Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -14.00M | 14.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -14.00M | 14.00M |
Log In |
Log In |
Log In | Upgrade
|